*Regional Center of Pharmacovigilance, Pharmacology Department, Cochin Hospital, AP-HP Centre-Université de Paris;
†Pharmacology Department, Cochin Hospital, AP-HP Centre-Université de Paris;
‡Pneumology Department, Cochin Hospital, AP-HP Centre-Université de Paris;
§Internal Medicine Department, Cochin Hospital, AP-HP Centre-Université de Paris;
¶Antimicrobial Stewardship Team, Cochin Hospital, AP-HP Centre-Université de Paris; and
‖Pharmacy Department, Cochin Hospital, AP-HP Centre-Université de Paris, Paris, France.
Correspondence: Laurent Chouchana, PharmD, PhD, Regional Center of Pharmacovigilance, Cochin Hospital, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France (e-mail: [email protected]).
Adverse drug reaction cases have been reported to the French pharmacovigilance system under the numbers PV20200174, PV20200224, and PV20200250-4.
L. Chouchana and S. Boujaafar authors contributed equally to the work. Study design: L. Chouchana, S. Boujaafar, I. Gana, J.-M. Treluyer, S. Benaboud. Data collection: L. Chouchana, S. Boujaafar, I. Gana, L.-H. Preta, L. Regard, P. Legendre, C. Azoulay, E. Canouï, J. Zerbit, N. Carlier, B. Terrier, S. Kernéis, R. Batista, J.-M. Treluyer, Y. Zheng, S. Benaboud. Data analysis: L. Chouchana, S. Boujaafar, L.-H. Preta, S. Benaboud. Drafted the manuscript: L. Chouchana, S. Boujaafar, S. Benaboud. Critically reviewed the manuscript: L. Chouchana, S. Boujaafar, E. Canouï, N. Carlier, B. Terrier, S. Kernéis. Approved the manuscript: L. Chouchana, S. Boujaafar, I. Gana, L.-H. Preta, L. Regard, P. Legendre, C. Azoulay, E. Canouï, J. Zerbit, N. Carlier, B. Terrier, S. Kernéis, R. Batista, J.-M. Treluyer, Y. Zheng, S. Benaboud.
The authors declare no conflict of interest.
